PhaseBio Pharmaceuticals Non-operating Income/Expense

Non-operating Income/Expense of PHAS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Non-operating Income/Expense growth rates and interactive chart. Income or expense that is usually non-recurring and not tied to a company's operations. It is stated separately on the income statement to differentiate it from operating expenses.


Highlights and Quick Summary

  • Non-operating Income/Expense for the quarter ending March 31, 2022 was $-7.23 Million (a -166.7% decrease compared to previous quarter)
  • Year-over-year quarterly Non-operating Income/Expense decreased by -225.22%
  • Annual Non-operating Income/Expense for 2021 was $21.2 Million (a 65.11% increase from previous year)
  • Annual Non-operating Income/Expense for 2020 was $12.8 Million (a 625.44% increase from previous year)
  • Annual Non-operating Income/Expense for 2019 was $1.77 Million (a 32.71% increase from previous year)
  • Twelve month Non-operating Income/Expense ending March 31, 2022 was $12.5 Million (a -40.86% decrease compared to previous quarter)
  • Twelve month trailing Non-operating Income/Expense decreased by -778.4% year-over-year
Trailing Non-operating Income/Expense for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
$12.5 Million $21.2 Million $5.95 Million $-1.85 Million
Visit stockrow.com/PHAS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Non-operating Income/Expense of PhaseBio Pharmaceuticals

Most recent Non-operating Income/Expenseof PHAS including historical data for past 10 years.

Interactive Chart of Non-operating Income/Expense of PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals Non-operating Income/Expense for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $-7.23
2021 $10.85 $3.14 $5.78 $1.42 $21.19
2020 $-4.4 $-4.65 $-4.04 $-0.62 $12.83
2019 $-0.05 $0.2 $0.25 $0.09 $1.77
2018 $2.79 $-2.9 $-2.57 $-1.53 $1.33
2017 $-0.67 $-0.96
2016 $-0.25

Business Profile of PhaseBio Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology